Gencurix Inc. (KOSDAQ:229000)
South Korea · Delayed Price · Currency is KRW 1,606.00
-32.00 (-1.95%)
Aug 29, 2025, 12:36 PM KST
Gencurix Market Cap
Gencurix has a market cap or net worth of 26.40 billion as of August 28, 2025. Its market cap has decreased by -30.90% in one year.
Market Cap
26.40B
Enterprise Value
29.00B
Revenue
3.39B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,606.00
Market Cap Chart
Since April 5, 2017, Gencurix's market cap has decreased from 73.36B to 26.40B, a decrease of -64.01%. That is a compound annual growth rate of -11.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2025 | 26.40B | -12.09% |
| Dec 30, 2024 | 30.03B | -64.40% |
| Dec 28, 2023 | 84.35B | 82.80% |
| Dec 29, 2022 | 46.15B | -60.69% |
| Dec 30, 2021 | 117.40B | 11.19% |
| Dec 30, 2020 | 105.58B | 18.66% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.60T |
| Celltrion | 37.63T |
| ALTEOGEN | 22.61T |
| Yuhan | 8,694.51B |
| SK Biopharmaceuticals | 7,893.98B |
| Peptron | 7,466.80B |
| PharmaResearch | 7,314.31B |
| LigaChem Biosciences | 5,419.69B |